Clinical Trial Update: Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing treat-to-target maintenance strategies versus routine care in Crohn's disease patients treated with ustekinumab has completed. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-05-19